The International Online Journal of Cancer & Therapeutics is a peer-reviewed open acess journal that publishes original research articles as well as review articles in all areas of Oncology. this practical journal also includes information on new products, new therapies and patient management, as well as reviews of the latest research. Cancer is a complex problem. The international effort to understand and control it involves clinicians trained in many branches of medicine and scientists from most biological disciplines, chemistry, pharmaceutical and physical sciences The International Online Journal of Cancer & Therapeutics exists to serve the needs of this diverse community, providing a forum for prompt communication of original and innovative research findings that have relevance to understanding the etiology of cancer and to improving the treatment and survival of patients.

The journal publishes important original studies, reviews, and perspectives within the major topic areas of biology of premalignancy, risk factors and risk assessment, early detection research, immunoprevention, and chemopreventive and other interventions, including the basic science behind them. This journal comprises preclinical, clinical and translational research, with special attention given to molecular discoveries and an emphasis on building a translational bridge between the basic and clinical sciences. Main focuses of interest include: systemic anticancer therapy (with specific interest on molecular targeted agents and new immune therapies), randomized trials (including negatives ones), top-level guidelines, and new fields currently emerging as key components of personalized medicine, such as molecular pathology, bioinformatics, modern statistics, and biotechnologies. Radiotherapy, surgery and pediatrics manuscripts can be considered if they display a clear interaction with one of the fields above or are paradigm-shifting.

Oncology is the diagnosis and treatment of cancers,including breast,prostate,colon,lung and ovarian cancers as well as brain tumors,leukemia,lymphoma and many other types of cancer.. A doctor who works in the field of oncology is called an oncologist. The primary regions of oncology are radiation, which is worried with radiation treatment, or radiotherapy; surgical, which is contained specialists who spend significant time in tumor evacuation; therapeutic, which manages disease drugs, including chemotherapy; and interventional, which includes interventional radiologists who have some expertise in insignificantly obtrusive picture guided tumor treatment.


committee

Members

ThumbnailImage

Xianquan Zhan

Professor and Deputy Director

Dr. Zhan received his undergraduate and graduate training in the fields of preventive
medicine and epidemiology and statistics at the West China University of Medical
Sciences in China during 1989 to 1999. He received his post-doctoral training in
oncology and cancer proteomics for two years at the Cancer Research Institute of
Human Medical University in China. In 2001, he went to the University of Tennessee
Health Science Center (UTHSC) in USA, where he was a post-doctoral researcher
and focused on mass spectrometry and cancer proteomics. Then, he was appointed as
an Assistant Professor of Neurology, UTHSC in 2005. He moved to the Cleveland
Clinic in USA as a Project Scientist/Staff in 2006 where he focused on the studies of
eye disease proteomics and biomarkers. He returned to UTHSC as an Assistant
Professor of Neurology in the end of 2007, engaging in proteomics and biomarker
studies of lung diseases and brain tumors, and initiating the studies of predictive,
preventive, and personalized medicine (PPPM) in cancer. In 2010, he was promoted
to Associate Professor of Neurology, UTHSC. Currently, he is a Professor at Xiangya
Hospital of Central South University in China, the European EPMA National
Representative in China, Associate Editors of BMC Genomics and of BMC Medical
Genomics. He has published 102 peer-reviewed research articles including about 75
articles in the field of disease proteomics and transcriptomics, 9 book chapters, and 2
US patents. His current main research interest focuses on the studies of cancer
proteomics and biomarkers, and the use of modern omics techniques and systems
biology for PPPM in cancer.

12/2015 - Hunan Province International Collaboration Award of Science and Technology.
12/2014 - Hunan “Hundred Talent Program” Member
09/2014 - Hunan Province 7th “Xiaoxiang Friendship Award”
12/2013 - Central South University “531” Talent Engineering
10/2013 - Hunan “225” Talent Engineering Expert in the field of Medicine
9/2013 -  Excellent Poster Award. CNHUPO 8th Congress, Chongqing, September 7-10, 2013.
7/2012 -  Excellent Poster Award. AOHUPO 6th Congress, Beijing, May 5-7, 2012.
1/2011 -  The EPMA-Journal Award-2010, the 1st place award
4/2010 - Young Neuroscientist Award funded by the Webster Endowment (http://www.uthsc.edu/ research/research_newsletter/docs/2010-04-April.pdf)
2/2007 - The National Eye Institute Travel Grant Award for the 2007 ARVO (Association for Research in Vision and Ophthalmology) Annual meeting (Fort Lauderdale, Florida, USA, May 6-10, 2007)
11/2005 - Hunan Province Scientific Technological Achievement Award, 1st place (No. 4 2005-230-064). Xiang Zheng Han [2005] No.190.
3/2005 - Hunan Province Medical Scientific Technological Achievement Award, 1st place (No. 200409). Xiang Yi Xue Hui Zi [2005] No.15.
1/2003 - Sichuan University Outstanding Doctoral Thesis Recognition Medal.
7/2000 - Chinese Postdoctoral Scientific Research Fund Prize (No.: Zhongboji[2000]23)
1997-1998 - The First Hongkong Union Medicine Education Medal
1996-1997 - Excellent graduate student cadre title of West China University of Medical Sciences
1996-1997 - Excellent graduate student scholarship of West China University of Medical Sciences
1994-1995 - Excellent graduate student scholarship of West China University of Medical Sciences